Unpacking TB-500's Chemical Blueprint: A PubChem Profile Deep Dive
Background
TB-500 is a synthetic peptide, a truncated version of the naturally occurring thymosin beta-4 protein. Thymosin beta-4 plays a crucial role in various biological processes, including cell migration, angiogenesis (the formation of new blood vessels), and tissue regeneration, making its synthetic derivatives like TB-500 of significant interest in regenerative medicine research. Before any biological activity can be explored, a precise and universally recognized chemical identification is paramount to ensure consistency and reproducibility across scientific investigations.
Results
The PubChem profile assigns TB-500 a unique Compound ID (CID) of 62707662, a critical identifier for database cross-referencing. Its molecular formula is precisely C38H68N10O14, indicating the exact count of carbon, hydrogen, nitrogen, and oxygen atoms within the peptide structure. This formula confirms its composition as a relatively small peptide. The molecular weight is accurately determined as 889.0 g/mol, a fundamental physical property essential for laboratory calculations and characterization. The detailed IUPAC name, (2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-3-hydroxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxybutanoyl]amino]-5-amino-5-oxopentanoic acid, provides an unambiguous, systematic description of its amino acid sequence and modifications, ensuring its exact chemical structure is known.
Why It Matters
Establishing a standardized chemical identity through resources like PubChem is foundational for all subsequent research into TB-500. It prevents ambiguity and ensures that studies conducted globally on this peptide are indeed investigating the exact same chemical entity, thereby enhancing scientific rigor and reproducibility. This precise chemical blueprint is indispensable for developing analytical methods, synthesizing the compound consistently, and ultimately for any future preclinical or clinical development aimed at exploring its therapeutic potential in areas like wound healing or tissue repair.